These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35791139)

  • 1. Evaluation of a revised care plan for babies with retinopathy of prematurity during SARS-CoV-2 pandemic in India.
    Suhan DN; Singh A; Bhusal U; Panchal B; Agarwal K; Nayak S; Nayak S; Jayanna S; Das T; Jalali S; Jadhav VS; Padhi TR
    Indian J Ophthalmol; 2022 Jul; 70(7):2480-2484. PubMed ID: 35791139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and future implications of COVID-19-related risk stratification for managing retinopathy of prematurity: The Indian twin cities retinopathy of prematurity study report number 10.
    Belenje A; Agarwal K; Naveen N; Sahoo NK; Parmeswarappa DC; Jayanna S; Padhi TR; Nayak S; Panchal B; Jalali S
    Indian J Ophthalmol; 2022 Sep; 70(9):3356-3361. PubMed ID: 36018120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of Screening Underlies Most Stage-5 Retinopathy of Prematurity among Cases Presenting to a Tertiary Eye Center in India.
    Azad R; Chandra P; Gangwe A; Kumar V
    Indian Pediatr; 2016 Nov; 53 Suppl 2():S103-S106. PubMed ID: 27915316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective study of factors influencing timely versus delayed presentation of preterm babies for retinopathy of prematurity screening at a tertiary eye hospital in India The Indian Twin Cities ROP Screening (ITCROPS) data base report number 6.
    Gopal DP; Rani PK; Rao HL; Jalali S
    Indian J Ophthalmol; 2019 Jun; 67(6):855-859. PubMed ID: 31124502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The safety and feasibility of the screening for retinopathy of prematurity assisted by telemedicine network during COVID-19 pandemic in Wuhan, China.
    Guo Z; Ma N; Wu Y; Yuan H; Luo W; Zeng L; Jie H; Li S
    BMC Ophthalmol; 2021 Jun; 21(1):258. PubMed ID: 34112134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the day-30 screening strategy on the disease presentation and outcome of retinopathy of prematurity. The Indian twin cities retinopathy of prematurity report number 3.
    Jalali S; Anand R; Rani PK; Balakrishnan D
    Indian J Ophthalmol; 2014 May; 62(5):610-4. PubMed ID: 24088643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of the COVID-19 lockdown on retinopathy of prematurity screening and management in the United States: a multicenter study.
    Sood S; Naguib MM; Portney DS; Besirli CG; Martin CA; Harper CA; Fernandez MP; Berrocal AM; Quiram PA; Belin P; Clarke N; Nagiel A; Chandler M; Bair C; Harnett ME; Dedania VS
    J AAPOS; 2023 Jun; 27(3):137.e1-137.e6. PubMed ID: 37164223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinopathy of prematurity: are we screening too many babies?
    Mathew MR; Fern AI; Hill R
    Eye (Lond); 2002 Sep; 16(5):538-42. PubMed ID: 12194065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and result of treatment-demanding retinopathy of prematurity using revised U.S. screening guidelines.
    Kuo HK; Chen CC; Chen YH; Huang HC; Liu CA; Chen FS; Chung MY
    Am J Perinatol; 2012 Nov; 29(10):827-31. PubMed ID: 22773294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening premature infants for retinopathy of prematurity in a tertiary hospital in Saudi Arabia.
    Mgharbil E; Raffa LH; Alessa S; Alamri A
    Ann Saudi Med; 2020; 40(2):87-93. PubMed ID: 32241163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reducing the Impact of the COVID-19 Pandemic on Retinopathy of Prematurity Screening: Successful Strategies Learnt from a Multi-Center Tele-Medicine Program in India.
    Vinekar A; Venkatesh R; Mangalesh S; Jayadev C; Shetty KB; Gilbert C
    Ophthalmic Epidemiol; 2024 Jun; 31(3):291-298. PubMed ID: 37646215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coincidental ocular findings during retinopathy of prematurity telescreening of 9105 neonates.
    Ranjan R; Das A; Prema S; Shah PK; Venkatapathy N
    Eur J Ophthalmol; 2022 Jan; 32(1):563-574. PubMed ID: 33719645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of COVID-19 Pandemic on Retinopathy of Prematurity Services in the Indian Public Healthcare System.
    Chakraborty S; Sheth JU
    Clin Ophthalmol; 2023; 17():2871-2877. PubMed ID: 37808002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe retinopathy of prematurity in big babies in India: history repeating itself?
    Shah PK; Narendran V; Kalpana N; Gilbert C
    Indian J Pediatr; 2009 Aug; 76(8):801-4. PubMed ID: 19802548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of an online screening algorithm - Weight, Insulin-derived growth factor 1, Neonatal Retinopathy of Prematurity (WINROP) for predicting retinopathy of prematurity in Indian preterm babies.
    Sute SS; Jain S; Chawla D; Narang S
    Indian J Ophthalmol; 2021 May; 69(5):1214-1218. PubMed ID: 33913863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ROP examination of premature babies at an eye hospital referred from urban and semi-urban NICUs.
    Venkatesh R; Dave PA; Gurav P; Agarwal M; Jajoo M; Gupta V
    Nepal J Ophthalmol; 2020 Jul; 12(24):226-235. PubMed ID: 33978617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinopathy of prematurity: incidence and risk factors.
    Rekha S; Battu RR
    Indian Pediatr; 1996 Dec; 33(12):999-1003. PubMed ID: 9141799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of COVID-19 pandemic lockdowns on retinopathy of prematurity services at a tertiary eye care center in India.
    Kaur R; Sachan A; Thukral A; Chandra P
    Indian J Ophthalmol; 2021 Oct; 69(10):2903-2904. PubMed ID: 34571682
    [No Abstract]   [Full Text] [Related]  

  • 19. Characteristics Of Preterm With Sight Threatening Retinopathy Of Prematurity.
    Hanif M; Ariff S; Ansar A; Ahmed K; Hussain AS
    J Ayub Med Coll Abbottabad; 2020; 32(2):174-178. PubMed ID: 32583989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RATES AND RISK FACTORS FOR RECURRENCE OF RETINOPATHY OF PREMATURITY AFTER LASER OR INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR MONOTHERAPY.
    Ling KP; Liao PJ; Wang NK; Chao AN; Chen KJ; Chen TL; Hwang YS; Lai CC; Wu WC
    Retina; 2020 Sep; 40(9):1793-1803. PubMed ID: 31800460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.